{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Clarke M"],"funding":["Sanofi"],"pagination":["1307"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11680122"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["12(12)"],"pubmed_abstract":["<h4>Background/objectives</h4>Influenza vaccination is recommended for pregnant women, offering the dual benefit of protecting pregnant women and their newborn infants against influenza. This study aimed to investigate the impact of body mass index (BMI) on influenza vaccine responses in pregnant women and their newborns.<h4>Methods</h4>Participants included pregnant women attending the Women's and Children's Hospital in South Australia between 2018 and 2021. Maternal blood samples were collected prior to and at 1 and 6 months post-influenza vaccination to measure antibody responses by hemagglutination inhibition (HI) assay. Cord blood samples were also collected. The percentages of participants achieving HI titre ≥40 were compared between obese and non-obese groups.<h4>Results</h4>A total"],"journal":["Vaccines"],"pubmed_title":["The Impact of Obesity on Influenza Vaccine Immunogenicity and Antibody Transfer to the Infant During Pregnancy."],"pmcid":["PMC11680122"],"funding_grant_id":["FLU00063"],"pubmed_authors":["Richmond PC","Marshall HS","Barr IG","Mathew SM","Giles LC","Clarke M"],"additional_accession":[]},"is_claimable":false,"name":"The Impact of Obesity on Influenza Vaccine Immunogenicity and Antibody Transfer to the Infant During Pregnancy.","description":"<h4>Background/objectives</h4>Influenza vaccination is recommended for pregnant women, offering the dual benefit of protecting pregnant women and their newborn infants against influenza. This study aimed to investigate the impact of body mass index (BMI) on influenza vaccine responses in pregnant women and their newborns.<h4>Methods</h4>Participants included pregnant women attending the Women's and Children's Hospital in South Australia between 2018 and 2021. Maternal blood samples were collected prior to and at 1 and 6 months post-influenza vaccination to measure antibody responses by hemagglutination inhibition (HI) assay. Cord blood samples were also collected. The percentages of participants achieving HI titre ≥40 were compared between obese and non-obese groups.<h4>Results</h4>A total","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Nov","modification":"2026-04-18T03:27:08.362Z","creation":"2026-04-18T03:13:29.596Z"},"accession":"S-EPMC11680122","cross_references":{"pubmed":["39771969"],"doi":["10.3390/vaccines12121307"]}}